Navigation Links
Equatorial Guinea's [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
Date:4/8/2013

WASHINGTON, April 8, 2013 /PRNewswire/ -- EG Ministry of Health recently met with Dr. Gloria B. Herndon of GB Group Global in the nation's capital as part of Equatorial Guinea's efforts to drastically raise its standards of health care. These endeavors include building a pharmaceutical manufacturing facility in EG, implementing pharmaceutical quality control and policies, and exploring the release of a new treatment (Low Dose Naltrexone) against cancer and HIV/AIDS.

The purpose of the visit of Dr. Diosdado-Vicente Milang Nsue, the Delegate Minister of Health & Social Services and Dr. Consuelo Ondo Efua , the Director General of Drug Supply and Medical equipment, was to engage with organizations who through assistance, partnership and the sharing of best-practices could close medical knowledge gaps and help bring improved health care to Equatorial Guineans.

Among issues discussed, Minister Dr. Milang Nsue raised a problem rampant overseas: The need for affordable high quality medicines. "The devastating effects of substandard and counterfeit medicines in circulation lead to treatment failure, increased mortality and the development of drug resistance."

Dr. Milang stressed the fact that "...establishing in Equatorial Africa a pharmaceutical manufacturing facility with an analytical laboratory would be of paramount importance..." The proposed facility was part of conversations with TNI Biotech (OTCBB:TNIB), GB-Energie, GB-Pharma, Howard University and the United States Pharmacopeia representatives.

Dr. Ondo Efua said, "With the establishment of a drug manufacturing facility to treat the most current pathologies and a laboratory for drug quality control we could guarantee the safety and high quality of medicines either produced in EG or imported. We would have taken an important step to halt the traffic and commercialization of the counterfeit medicines that undermine the quality of the health services delivered to our population."

Further, as EG is concerned in the global struggle to combat the scourge of diseases such as HIV/AIDS and cancer, new developments regarding the therapy known as IRT-103 Low Dose Naltrexone were explained during the sessions.

Concluding the sessions, Dr. Herndon said she felt the exchanges had been productive and pleased that "...we (GB Group Global) were able to demonstrate our commitment to viable and sustainable solutions to the issues of the citizens well being and the growth of the nation."

www.gbenergie.com


'/>"/>
SOURCE GB Group Global
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AUL says New York Judges Ruling Allows Big Abortion to Gamble with Young Girls Health
2. Dynamic Healthcare Services Announces David Erb as Director of Sales
3. Healthcare Coalitions Across the Nation Band Together to Ready for Disasters
4. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
5. Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
6. Armada Health Care Achieves Full URAC Accreditation
7. Kimberly-Clark Health Care Acquires Anesthesia Business from Life-Tech
8. Healthrageous Unveils Accountable Health The Missing Piece To Engage Consumers In Their Health And Achieve Accountable Care Goals
9. Healthcare Tech developers ENuke Software LLC proud to announce completion of eBroselowLutens Artemis in Dutch, German, Portugese and Spanish
10. Everyday Health Expands Solutions For Pharmaceutical Industry Marketers
11. Saint Francis Signs Agreement to Upgrade and Extend the Use of Streamline Healths(R) Solutions for Five More Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... 3, 2016  Specialty Silicone Fabricators is offering ... how a cleanroom works. The free visual aid ... and technology. Chris Mazelin ... company, SSF enthusiastically supports the Science, Technology, Engineering ... the next generation of innovators. We want to ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... ... Recognizing that lifestyle medicine is essential to health and healthcare, About.com ... MD, MPH, president of the American College of Lifestyle Medicine, as their first senior ... said Katz. “There is so much opportunity to add years to lives, and life ...
(Date:5/4/2016)... Carlsbad, CA (PRWEB) , ... May 04, 2016 , ... ... has recently partnered with local company MitoXcell in preparation of the launch of her ... day jump start plan is a nutritional guide designed to jump start a new ...
(Date:5/4/2016)... , ... May 04, 2016 , ... The preeminent surgical ... Janice Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and ... of breast cancer that occurs in the milk ducts, according to an interview ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Advanced ... technology to help restore its patients’ health, is hosting a free seminar on stem ... will be held at Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... ankles, and elbows. Engineered with athletes in mind, OMNIFORCE offers high-performance, less ... ineffective circular knitting, common in the industry) produces premium flat-knit construction with ...
Breaking Medicine News(10 mins):